Selcuk Ecza Deposu Ticaret venayi ASIST:SELEC +6.80%79 Return-on-Tangible-Equity is 19.68% as of Mar. 2026, which is 37% above its 10-year median of 14.41. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺87.25 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 111 Medical Distribution companies, Selcuk Ecza Deposu Ticaret venayi AS ranks worse than 69.37% on this metric.
The historical rank and industry rank for Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity or its related term are showing as below:
IST:SELEC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -1.29 Med: 14.41 Max: 25.29
Current: 4.18
During the past 13 years, Selcuk Ecza Deposu Ticaret venayi AS's highest Return-on-Tangible-Equity was 25.29%. The lowest was -1.29%. And the median was 14.41%.
IST:SELEC's Return-on-Tangible-Equity is ranked worse than 69.37% of 111
companies
in the Medical Distribution industry
Industry Median: 8.81
vs IST:SELEC: 4.18
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Equity Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Equity Chart
IST:SELEC vs MCK, CAH, COR: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.68% mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Return-on-Tangible-Equity of 19.68% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is 37% above median its historical median of 14.41. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #77 out of 111 companies in the Medical Distribution industry, placing it in the top 69.4%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Equity of 19.68% is 37% above median its 10-year median of 14.41. The Medical Distribution industry median Return-on-Tangible-Equity is 8.81. Selcuk Ecza Deposu Ticaret venayi AS's value of 19.68% is 123.4% above this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #77 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Return-on-Tangible-Equity compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #77 out of 111 companies for Return-on-Tangible-Equity. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.81. Selcuk Ecza Deposu Ticaret venayi AS's value of 19.68% is 123.4% above this benchmark. While the company's 10-year median is 14.41 vs. the industry median of 8.81, Selcuk Ecza Deposu Ticaret venayi AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.81, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Equity of 19.68% is 123.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Return-on-Tangible-Equity is 19.68%, which is 37% above median its own 10-year median of 14.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺87.25, compared to a current price of ₺223.00 — trading 155.6% above its estimated fair value. The current Return-on-Tangible-Equity is 19.68%, which is 37% above median its 10-year median of 14.41 and 123.4% above the Medical Distribution industry median of 8.81. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Return-on-Tangible-Equity is 19.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺223.00 is trading 155.6% above its estimated GF Value™ of ₺87.25.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Return-on-Tangible-Equity: 19.68% (37% above median its 10-year median of 14.41)
GF Value™: ₺87.25 vs. price of ₺223.00 (155.6% above fair value)
Industry Position: 123.4% above the Medical Distribution median (#77 of 111)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score
Get the complete analysis for IST:SELEC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
